Finance

Lists
KZIA:NASDAQ
Kazia Therapeutics Ltd
$9.29
+0.32%
(+0.030) 1D
Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KZIA...
Open
$9.20
High
$9.53
Low
$9.14
Mkt. cap
141.63M
Avg. vol.
346.81K
Volume
0.00
52-wk high
$17.40
52-wk low
$4.86
EPS
-$6.35
Beta
2.68
Shares outstanding
15.25M
No. of employees
6
Open
$9.20
High
$9.53
Low
$9.14
Mkt. cap
141.63M
Avg. vol.
346.81K
Volume
0.00
52-wk high
$17.40
52-wk low
$4.86
EPS
-$6.35
Beta
2.68
Shares outstanding
15.25M
No. of employees
6
News stories
From web sources and news partners
About Kazia Therapeutics Ltd
CEO-
Employees6
Founded1994
Headquarters-
SectorBiotechnology
Websitekaziatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to KZIA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KZIA in the last 3 months.
Highest
Current $9.29
$40.00 (+330.57%)
Average
$29.25 (+214.85%)
Lowest
$18.00 (+93.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$18.00
+93.8%
10/01/2026
Kambiz Yazdi
BTIG
Buy
Maintained
$40.00
+330.6%
09/22/2026
John Newman
Canaccord Genuity
Buy
Reiterated
$29.00
+212.2%
09/01/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
$29.00
+212.2%
08/13/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$30.00
+222.9%
07/15/2026
Chad Messer
Lake Street
Buy
Initiated
$32.00
+244.5%
06/11/2026
Yale Jen
Laidlaw
Buy
Initiated
$25.00
+169.1%
04/15/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
903.36K
903.36K
45.96K
45.96K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.52M
1.52M
2.50M
2.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.81M
1.81M
4.28M
4.28M
Operating expense
3.33M
3.33M
6.78M
6.78M
Total operating expenses
3.33M
3.33M
6.78M
6.78M
Operating income
-2.42M
-2.42M
-6.73M
-6.73M
Other non operating income
-239.18K
-239.18K
372.46K
372.46K
EBT including unusual items
-5.93M
-5.93M
-6.28M
-6.28M
EBT excluding unusual items
-2.64M
-2.64M
-6.28M
-6.28M
Income tax expense
-805.23K
-805.23K
-
-
Effective tax rate
13.58%
13.58%
-
-
Other operating expenses
-
-
-
-
Net income
-5.12M
-5.12M
-6.28M
-6.28M
Net profit margin
-567.23%
-567.23%
-13,655.59%
-13,655.59%
Earnings per share
-
-
-
-
Interest and investment income
21.67K
21.67K
80.46K
80.46K
Interest expense
-
-
-
-
Net interest expenses
21.67K
21.67K
80.46K
80.46K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.11M
-2.19M
-6.50M
-6.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps